Ceragon Has Further To Run

  • The company had a good second quarter and there are several tailwinds blowing, despite the residual uncertainty with respect to the pandemic.
  • Gross profits are set to increase meaningfully in Q3 with the company returning to more normal revenue and gross margin ranges.
  • While a good deal of the recovery is already priced in, the shares have some further room to run.

Source: Ceragon Has Further To Run (NASDAQ:CRNT) | Seeking Alpha